Next Article in Journal
An HIV Vaccine for South-East Asia—Opportunities and Challenges
Previous Article in Journal
Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection
Previous Article in Special Issue
A Multidisciplinary Research Agenda for Understanding Vaccine-Related Decisions
Vaccines 2013, 1(3), 343-347; doi:10.3390/vaccines1030343

Trust in Vaccines: Why It Takes More than Good Faith

Chief Medical Officer, GlaxoSmithKline Vaccines, Avenue Fleming, 1300 Wavre, Belgium
Received: 29 May 2013 / Revised: 21 June 2013 / Accepted: 10 July 2013 / Published: 12 August 2013
(This article belongs to the Special Issue Confidence in Vaccines)
View Full-Text   |   Download PDF [218 KB, uploaded 12 August 2013]


This Vaccines issue on “Confidence in Vaccines” provides sound evidence through multiple perspectives of life-saving impacts when vaccination programs are effectively implemented in a population. Yet there remain challenges to achieving this impact, including scientific, medical, manufacturing, policy-related and logistical issues. Additionally, socio-cultural, religious and political agendas can come into play, taking public health hostage and sometimes allowing the circulation of myths regarding vaccination. All of these challenges play a role in public confidence in vaccines and vaccination. What we trust, we embrace. What we do not trust, we do not embrace.
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Begg, N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines 2013, 1, 343-347.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert